Hepatic and renal blood flow responses to a clinical dose of intravenous cyclosporine in the pig

Kenneth A. Andreoni, Christopher P. O'Donnell, James F. Burdick, James L. Robotham

Research output: Contribution to journalArticle

Abstract

The immunosuppressant Cyclosporine A (CsA) is considered to induce nephrotoxicity in part by causing vasoconstriction of the glomerular afferent arterioles. Although CsA is widely used in hepatic transplantation, little is known concerning its effects on hepatic blood flow. We used ultrasonic flow probes in an anesthetized swine model to measure the effects of a single 60 min infusion of a clinically comparable dose of CsA (5 mg/kg per h) on hepatic, renal, and supraceliac descending aortic blood flows (n = 7 swine). To account for any changes in systemic output or systemic vascular resistance during the 60 min CsA infusion that may non-specifically affect hepatic and renal blood flows, the total hepatic (portal vein plus hepatic artery) and renal blood flows were reported relative to the supraceliac descending aortic blood flow (termed 'fractional' total hepatic and renal blood flows). The fractional total hepatic blood flow decreased significantly (p <0.05) by 40 min of CsA infusion vs baseline, and continued to decrease throughout the infusion (baseline = 0.38 ± 0.03 units vs 0.28 ± 0.05 units by 60 min of CsA infusion). During the recovery period, the fractional total hepatic blood flow increased to a value which was not different from baseline (recovery = 0.38 ± 0.03 units). Fractional right renal artery blood flow did not change significantly from baseline at any time during the CsA infusion or during the recovery period. We conclude that a single, clinically comparable dose of CsA results in a significant decrease in total hepatic blood flow, and that this decrease is greater than that seen in renal blood flow.

Original languageEnglish (US)
Pages (from-to)87-94
Number of pages8
JournalImmunopharmacology
Volume28
Issue number2
DOIs
StatePublished - 1994

Fingerprint

Renal Circulation
Cyclosporine
Swine
Liver
Hepatic Veins
Hepatic Artery
Arterioles
Renal Artery
Immunosuppressive Agents
Portal Vein
Vasoconstriction
Ultrasonics
Vascular Resistance
Liver Transplantation
Kidney

Keywords

  • Blood flow
  • Cyclosporine A
  • Liver
  • Pig
  • Toxicity

ASJC Scopus subject areas

  • Pharmacology

Cite this

Hepatic and renal blood flow responses to a clinical dose of intravenous cyclosporine in the pig. / Andreoni, Kenneth A.; O'Donnell, Christopher P.; Burdick, James F.; Robotham, James L.

In: Immunopharmacology, Vol. 28, No. 2, 1994, p. 87-94.

Research output: Contribution to journalArticle

Andreoni, Kenneth A. ; O'Donnell, Christopher P. ; Burdick, James F. ; Robotham, James L. / Hepatic and renal blood flow responses to a clinical dose of intravenous cyclosporine in the pig. In: Immunopharmacology. 1994 ; Vol. 28, No. 2. pp. 87-94.
@article{a7da36aed6514eefa640bff00a8dbddc,
title = "Hepatic and renal blood flow responses to a clinical dose of intravenous cyclosporine in the pig",
abstract = "The immunosuppressant Cyclosporine A (CsA) is considered to induce nephrotoxicity in part by causing vasoconstriction of the glomerular afferent arterioles. Although CsA is widely used in hepatic transplantation, little is known concerning its effects on hepatic blood flow. We used ultrasonic flow probes in an anesthetized swine model to measure the effects of a single 60 min infusion of a clinically comparable dose of CsA (5 mg/kg per h) on hepatic, renal, and supraceliac descending aortic blood flows (n = 7 swine). To account for any changes in systemic output or systemic vascular resistance during the 60 min CsA infusion that may non-specifically affect hepatic and renal blood flows, the total hepatic (portal vein plus hepatic artery) and renal blood flows were reported relative to the supraceliac descending aortic blood flow (termed 'fractional' total hepatic and renal blood flows). The fractional total hepatic blood flow decreased significantly (p <0.05) by 40 min of CsA infusion vs baseline, and continued to decrease throughout the infusion (baseline = 0.38 ± 0.03 units vs 0.28 ± 0.05 units by 60 min of CsA infusion). During the recovery period, the fractional total hepatic blood flow increased to a value which was not different from baseline (recovery = 0.38 ± 0.03 units). Fractional right renal artery blood flow did not change significantly from baseline at any time during the CsA infusion or during the recovery period. We conclude that a single, clinically comparable dose of CsA results in a significant decrease in total hepatic blood flow, and that this decrease is greater than that seen in renal blood flow.",
keywords = "Blood flow, Cyclosporine A, Liver, Pig, Toxicity",
author = "Andreoni, {Kenneth A.} and O'Donnell, {Christopher P.} and Burdick, {James F.} and Robotham, {James L.}",
year = "1994",
doi = "10.1016/0162-3109(94)90024-8",
language = "English (US)",
volume = "28",
pages = "87--94",
journal = "Immunopharmacology",
issn = "0162-3109",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Hepatic and renal blood flow responses to a clinical dose of intravenous cyclosporine in the pig

AU - Andreoni, Kenneth A.

AU - O'Donnell, Christopher P.

AU - Burdick, James F.

AU - Robotham, James L.

PY - 1994

Y1 - 1994

N2 - The immunosuppressant Cyclosporine A (CsA) is considered to induce nephrotoxicity in part by causing vasoconstriction of the glomerular afferent arterioles. Although CsA is widely used in hepatic transplantation, little is known concerning its effects on hepatic blood flow. We used ultrasonic flow probes in an anesthetized swine model to measure the effects of a single 60 min infusion of a clinically comparable dose of CsA (5 mg/kg per h) on hepatic, renal, and supraceliac descending aortic blood flows (n = 7 swine). To account for any changes in systemic output or systemic vascular resistance during the 60 min CsA infusion that may non-specifically affect hepatic and renal blood flows, the total hepatic (portal vein plus hepatic artery) and renal blood flows were reported relative to the supraceliac descending aortic blood flow (termed 'fractional' total hepatic and renal blood flows). The fractional total hepatic blood flow decreased significantly (p <0.05) by 40 min of CsA infusion vs baseline, and continued to decrease throughout the infusion (baseline = 0.38 ± 0.03 units vs 0.28 ± 0.05 units by 60 min of CsA infusion). During the recovery period, the fractional total hepatic blood flow increased to a value which was not different from baseline (recovery = 0.38 ± 0.03 units). Fractional right renal artery blood flow did not change significantly from baseline at any time during the CsA infusion or during the recovery period. We conclude that a single, clinically comparable dose of CsA results in a significant decrease in total hepatic blood flow, and that this decrease is greater than that seen in renal blood flow.

AB - The immunosuppressant Cyclosporine A (CsA) is considered to induce nephrotoxicity in part by causing vasoconstriction of the glomerular afferent arterioles. Although CsA is widely used in hepatic transplantation, little is known concerning its effects on hepatic blood flow. We used ultrasonic flow probes in an anesthetized swine model to measure the effects of a single 60 min infusion of a clinically comparable dose of CsA (5 mg/kg per h) on hepatic, renal, and supraceliac descending aortic blood flows (n = 7 swine). To account for any changes in systemic output or systemic vascular resistance during the 60 min CsA infusion that may non-specifically affect hepatic and renal blood flows, the total hepatic (portal vein plus hepatic artery) and renal blood flows were reported relative to the supraceliac descending aortic blood flow (termed 'fractional' total hepatic and renal blood flows). The fractional total hepatic blood flow decreased significantly (p <0.05) by 40 min of CsA infusion vs baseline, and continued to decrease throughout the infusion (baseline = 0.38 ± 0.03 units vs 0.28 ± 0.05 units by 60 min of CsA infusion). During the recovery period, the fractional total hepatic blood flow increased to a value which was not different from baseline (recovery = 0.38 ± 0.03 units). Fractional right renal artery blood flow did not change significantly from baseline at any time during the CsA infusion or during the recovery period. We conclude that a single, clinically comparable dose of CsA results in a significant decrease in total hepatic blood flow, and that this decrease is greater than that seen in renal blood flow.

KW - Blood flow

KW - Cyclosporine A

KW - Liver

KW - Pig

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=0028145623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028145623&partnerID=8YFLogxK

U2 - 10.1016/0162-3109(94)90024-8

DO - 10.1016/0162-3109(94)90024-8

M3 - Article

VL - 28

SP - 87

EP - 94

JO - Immunopharmacology

JF - Immunopharmacology

SN - 0162-3109

IS - 2

ER -